Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

zerbaxa

ceftolozane-tazobactam
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zerbaxa POWDER FOR INJECTION, INTRAVENOUS 1 g-0.5 g      


Comments:

ZERBAXA is classified as formulary restricted to ID for documented MDR Pseudomonas when other options are not appropriate.


Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information.  CrCl calculation policy available here.


Reviewed: 24 March 2015 and 28 March 2017


Last updated: Jul. 16, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.